Nathan Rice
Stock Analyst at Piper Sandler
(3.84)
# 531
Out of 4,789 analysts
51
Total ratings
48.48%
Success rate
10.87%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $53 → $57 | $36.84 | +53.37% | 7 | Jan 30, 2025 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $46 → $47 | $34.75 | +35.25% | 3 | Nov 1, 2024 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $26.40 | +28.79% | 8 | Oct 29, 2024 | |
| BFC Bank First | Maintains: Neutral | $99 → $104 | $101.57 | +2.39% | 5 | Oct 17, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $67.98 | +8.86% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $109.31 | -23.15% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $158.08 | +24.62% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $10.35 | -13.04% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $418.57 | +3.93% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $331.00 | -29.61% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $60.45 | +37.30% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $16.61 | -9.69% | 1 | Dec 19, 2019 | |
Merchants Bancorp
Jan 30, 2025
Maintains: Overweight
Price Target: $53 → $57
Current: $36.84
Upside: +53.37%
First Mid Bancshares
Nov 1, 2024
Maintains: Overweight
Price Target: $46 → $47
Current: $34.75
Upside: +35.25%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $26.40
Upside: +28.79%
Bank First
Oct 17, 2024
Maintains: Neutral
Price Target: $99 → $104
Current: $101.57
Upside: +2.39%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $67.98
Upside: +8.86%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $109.31
Upside: -23.15%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $158.08
Upside: +24.62%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $10.35
Upside: -13.04%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $418.57
Upside: +3.93%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $331.00
Upside: -29.61%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $60.45
Upside: +37.30%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $16.61
Upside: -9.69%